世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ヒト由来オルガノイドの世界市場 2022-2026


Global Human Organoids Market 2022-2026

ヒト由来オルガノイドの世界市場 2022-2026 年 Technavioは、ヒト由来オルガノイド市場を監視しており、2022-2026年の間に11億8000万ドルの成長が見込まれ、予測期間中にCAGR16.9%で加速しています。当レポート... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年6月28日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

ヒト由来オルガノイドの世界市場 2022-2026 年
Technavioは、ヒト由来オルガノイド市場を監視しており、2022-2026年の間に11億8000万ドルの成長が見込まれ、予測期間中にCAGR16.9%で加速しています。当レポートでは、ヒト由来オルガネラ市場の全体分析、市場規模と予測、トレンド、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境について最新の分析を提供しています。市場は、従来の方法に対するヒトオルガノイドの利点、疾患モデル化のためのヒトオルガノイドの普及の増加、感染症に対するヒトオルガノイドの普及の増加によって推進されています。
ヒトオルガノイド市場の分析には、エンドユーザーセグメントと地理的な状況が含まれます。
Technavioのヒトオルガノイド市場は、以下のようにセグメント化されています。
エンドユーザー別
- 製薬会社、バイオテクノロジー会社
- 受託研究機関
- 学術・研究機関
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、ベンダー間のM&A、コラボレーション、パートナーシップは、今後数年間のヒトオルガノイド市場の成長を促進する主要な理由の1つであると特定しています。また、バイオプリンティング技術の出現と、医療の個別化開発におけるヒトオルガノイドの応用の拡大が、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ヒト由来オルガノイド市場に関する当レポートの対象領域は以下の通りです。
- ヒト由来オルガネラの市場サイジング
- ヒト由来オルガネラの市場予測
- ヒト由来オルガネラ市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、BICO Group AB, BioIVT LLC, Biopredic International, Cellesce Ltd., CN Bio Innovations Ltd.を含むいくつかの主要ヒトオルゴナイト市場ベンダーについて詳細に分析を行っています。Corning Inc.、DefiniGEN Ltd.、Emulate Inc.、Hubrecht Organoid Technology、InSphero AG、Kirkstall Ltd.、Merck KGaA、MIMETAS BV、Miromatrix Medical Inc、Organoid Therapeutics、Organovo Holdings Inc、Pandorum Technologies Pvt. Ltd、STEMCELL Technologies Inc、Thermo Fisher Scientific Inc、および ZenBio Inc.などの大手ベンダーがあります。また、ヒト由来オルガノイド市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、包括的な市場およびベンダーの状況、主要ベンダーの分析が含まれています。本レポートの詳細については、以下をご覧ください。 - https://www.technavio.com/report/human-organoids-market-industry-analysis
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータを調査、合成、総括する方法で、市場の詳細なイメージを提示します。業界の主要な影響力を持つ人物を特定することで、様々な市場の様相を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
o Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
o 5.2 Comparison by End-user
o Exhibit 26: Chart on Comparison by End-user
o Exhibit 27: Data Table on Comparison by End-user
o 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
o 5.4 Contract research organizations - Market size and forecast 2021-2026
o Exhibit 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
o 5.5 Academic and research institutes - Market size and forecast 2021-2026
o Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by End-user
o Exhibit 44: Market opportunity by End-user ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 BioIVT LLC
o Exhibit 93: BioIVT LLC - Overview
o Exhibit 94: BioIVT LLC - Product / Service
o Exhibit 95: BioIVT LLC - Key news
o Exhibit 96: BioIVT LLC - Key offerings
o 10.4 Cellesce Ltd.
o Exhibit 97: Cellesce Ltd. - Overview
o Exhibit 98: Cellesce Ltd. - Product / Service
o Exhibit 99: Cellesce Ltd. - Key offerings
o 10.5 Corning Inc.
o Exhibit 100: Corning Inc. - Overview
o Exhibit 101: Corning Inc. - Business segments
o Exhibit 102: Corning Inc. - Key offerings
o Exhibit 103: Corning Inc. - Segment focus
o 10.6 DefiniGEN Ltd.
o Exhibit 104: DefiniGEN Ltd. - Overview
o Exhibit 105: DefiniGEN Ltd. - Product / Service
o Exhibit 106: DefiniGEN Ltd. - Key offerings
o 10.7 Emulate Inc.
o Exhibit 107: Emulate Inc. - Overview
o Exhibit 108: Emulate Inc. - Product / Service
o Exhibit 109: Emulate Inc. - Key offerings
o 10.8 Hubrecht Organoid Technology
o Exhibit 110: Hubrecht Organoid Technology - Overview
o Exhibit 111: Hubrecht Organoid Technology - Product / Service
o Exhibit 112: Hubrecht Organoid Technology - Key offerings
o 10.9 Merck KGaA
o Exhibit 113: Merck KGaA - Overview
o Exhibit 114: Merck KGaA - Business segments
o Exhibit 115: Merck KGaA - Key news
o Exhibit 116: Merck KGaA - Key offerings
o Exhibit 117: Merck KGaA - Segment focus
o 10.10 Organoid Therapeutics
o Exhibit 118: Organoid Therapeutics - Overview
o Exhibit 119: Organoid Therapeutics - Product / Service
o Exhibit 120: Organoid Therapeutics - Key offerings
o 10.11 STEMCELL Technologies Inc.
o Exhibit 121: STEMCELL Technologies Inc. - Overview
o Exhibit 122: STEMCELL Technologies Inc. - Product / Service
o Exhibit 123: STEMCELL Technologies Inc. - Key offerings
o 10.12 ZenBio Inc.
o Exhibit 124: ZenBio Inc. - Overview
o Exhibit 125: ZenBio Inc. - Product / Service
o Exhibit 126: ZenBio Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations
o investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on End-user - Market share 2021-2026 (%)
Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by End-user
Exhibits27: Data Table on Comparison by End-user
Exhibits28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by End-user ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: BioIVT LLC - Overview
Exhibits94: BioIVT LLC - Product / Service
Exhibits95: BioIVT LLC - Key news
Exhibits96: BioIVT LLC - Key offerings
Exhibits97: Cellesce Ltd. - Overview
Exhibits98: Cellesce Ltd. - Product / Service
Exhibits99: Cellesce Ltd. - Key offerings
Exhibits100: Corning Inc. - Overview
Exhibits101: Corning Inc. - Business segments
Exhibits102: Corning Inc. - Key offerings
Exhibits103: Corning Inc. - Segment focus
Exhibits104: DefiniGEN Ltd. - Overview
Exhibits105: DefiniGEN Ltd. - Product / Service
Exhibits106: DefiniGEN Ltd. - Key offerings
Exhibits107: Emulate Inc. - Overview
Exhibits108: Emulate Inc. - Product / Service
Exhibits109: Emulate Inc. - Key offerings
Exhibits110: Hubrecht Organoid Technology - Overview
Exhibits111: Hubrecht Organoid Technology - Product / Service
Exhibits112: Hubrecht Organoid Technology - Key offerings
Exhibits113: Merck KGaA - Overview
Exhibits114: Merck KGaA - Business segments
Exhibits115: Merck KGaA - Key news
Exhibits116: Merck KGaA - Key offerings
Exhibits117: Merck KGaA - Segment focus
Exhibits118: Organoid Therapeutics - Overview
Exhibits119: Organoid Therapeutics - Product / Service
Exhibits120: Organoid Therapeutics - Key offerings
Exhibits121: STEMCELL Technologies Inc. - Overview
Exhibits122: STEMCELL Technologies Inc. - Product / Service
Exhibits123: STEMCELL Technologies Inc. - Key offerings
Exhibits124: ZenBio Inc. - Overview
Exhibits125: ZenBio Inc. - Product / Service
Exhibits126: ZenBio Inc. - Key offerings
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Human Organoids Market 2022-2026
Technavio has been monitoring the human organoids market and it is poised to grow by $ 1.18 bn during 2022-2026, accelerating at a CAGR of 16.9% during the forecast period. Our report on the human organoids market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the advantages of human organoids over traditional methods, the increasing prevalence of human organoids for disease modeling, and the growing prevalence of human organoids for infectious diseases.
The human organoids market analysis includes the end-user segment and geographic landscape.
Technavio's human organoids market is segmented as below:
By End-user
• Pharmaceutical and biotechnology companies
• Contract research organizations
• Academic and research institutes
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the mergers and acquisitions, collaborations, and partnerships among vendors as one of the prime reasons driving the human organoids market growth during the next few years. Also, the emergence of bioprinting technology and the growing application of human organoids in medicine personalized development will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the human organoids market covers the following areas:
• Human organoids market sizing
• Human organoids market forecast
• Human organoids market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human organoids market vendors that include BICO Group AB, BioIVT LLC, Biopredic International, Cellesce Ltd., CN Bio Innovations Ltd., Corning Inc., DefiniGEN Ltd., Emulate Inc., Hubrecht Organoid Technology, InSphero AG, Kirkstall Ltd., Merck KGaA, MIMETAS BV, Miromatrix Medical Inc., Organoid Therapeutics, Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., and ZenBio Inc. Also, the human organoids market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/human-organoids-market-industry-analysis
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by End-user
o 5.1 Market segments
o Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
o Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
o 5.2 Comparison by End-user
o Exhibit 26: Chart on Comparison by End-user
o Exhibit 27: Data Table on Comparison by End-user
o 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026
o Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
o 5.4 Contract research organizations - Market size and forecast 2021-2026
o Exhibit 32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
o 5.5 Academic and research institutes - Market size and forecast 2021-2026
o Exhibit 36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by End-user
o Exhibit 44: Market opportunity by End-user ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 BioIVT LLC
o Exhibit 93: BioIVT LLC - Overview
o Exhibit 94: BioIVT LLC - Product / Service
o Exhibit 95: BioIVT LLC - Key news
o Exhibit 96: BioIVT LLC - Key offerings
o 10.4 Cellesce Ltd.
o Exhibit 97: Cellesce Ltd. - Overview
o Exhibit 98: Cellesce Ltd. - Product / Service
o Exhibit 99: Cellesce Ltd. - Key offerings
o 10.5 Corning Inc.
o Exhibit 100: Corning Inc. - Overview
o Exhibit 101: Corning Inc. - Business segments
o Exhibit 102: Corning Inc. - Key offerings
o Exhibit 103: Corning Inc. - Segment focus
o 10.6 DefiniGEN Ltd.
o Exhibit 104: DefiniGEN Ltd. - Overview
o Exhibit 105: DefiniGEN Ltd. - Product / Service
o Exhibit 106: DefiniGEN Ltd. - Key offerings
o 10.7 Emulate Inc.
o Exhibit 107: Emulate Inc. - Overview
o Exhibit 108: Emulate Inc. - Product / Service
o Exhibit 109: Emulate Inc. - Key offerings
o 10.8 Hubrecht Organoid Technology
o Exhibit 110: Hubrecht Organoid Technology - Overview
o Exhibit 111: Hubrecht Organoid Technology - Product / Service
o Exhibit 112: Hubrecht Organoid Technology - Key offerings
o 10.9 Merck KGaA
o Exhibit 113: Merck KGaA - Overview
o Exhibit 114: Merck KGaA - Business segments
o Exhibit 115: Merck KGaA - Key news
o Exhibit 116: Merck KGaA - Key offerings
o Exhibit 117: Merck KGaA - Segment focus
o 10.10 Organoid Therapeutics
o Exhibit 118: Organoid Therapeutics - Overview
o Exhibit 119: Organoid Therapeutics - Product / Service
o Exhibit 120: Organoid Therapeutics - Key offerings
o 10.11 STEMCELL Technologies Inc.
o Exhibit 121: STEMCELL Technologies Inc. - Overview
o Exhibit 122: STEMCELL Technologies Inc. - Product / Service
o Exhibit 123: STEMCELL Technologies Inc. - Key offerings
o 10.12 ZenBio Inc.
o Exhibit 124: ZenBio Inc. - Overview
o Exhibit 125: ZenBio Inc. - Product / Service
o Exhibit 126: ZenBio Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations
o investments in R and D by biotechnology firms and federal agencies: Biotechnology companies and research organizations are investing significantly in R and D activities to develop new technologies to improve the quality and standards of their products. They are investing in proteomics, drug testing, high-throughput screening, combinational chemistry, and the development of highly innovative environment-friendly biotechnology reagents. Increased R and D has led to improved healthcare access in the US, countries in Europe, as well as in emerging markets such as China and India, which drives the demand for biotechnology reagents.


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on End-user - Market share 2021-2026 (%)
Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by End-user
Exhibits27: Data Table on Comparison by End-user
Exhibits28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Contract research organizations - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Contract research organizations - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Academic and research institutes - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Academic and research institutes - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by End-user ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: BioIVT LLC - Overview
Exhibits94: BioIVT LLC - Product / Service
Exhibits95: BioIVT LLC - Key news
Exhibits96: BioIVT LLC - Key offerings
Exhibits97: Cellesce Ltd. - Overview
Exhibits98: Cellesce Ltd. - Product / Service
Exhibits99: Cellesce Ltd. - Key offerings
Exhibits100: Corning Inc. - Overview
Exhibits101: Corning Inc. - Business segments
Exhibits102: Corning Inc. - Key offerings
Exhibits103: Corning Inc. - Segment focus
Exhibits104: DefiniGEN Ltd. - Overview
Exhibits105: DefiniGEN Ltd. - Product / Service
Exhibits106: DefiniGEN Ltd. - Key offerings
Exhibits107: Emulate Inc. - Overview
Exhibits108: Emulate Inc. - Product / Service
Exhibits109: Emulate Inc. - Key offerings
Exhibits110: Hubrecht Organoid Technology - Overview
Exhibits111: Hubrecht Organoid Technology - Product / Service
Exhibits112: Hubrecht Organoid Technology - Key offerings
Exhibits113: Merck KGaA - Overview
Exhibits114: Merck KGaA - Business segments
Exhibits115: Merck KGaA - Key news
Exhibits116: Merck KGaA - Key offerings
Exhibits117: Merck KGaA - Segment focus
Exhibits118: Organoid Therapeutics - Overview
Exhibits119: Organoid Therapeutics - Product / Service
Exhibits120: Organoid Therapeutics - Key offerings
Exhibits121: STEMCELL Technologies Inc. - Overview
Exhibits122: STEMCELL Technologies Inc. - Product / Service
Exhibits123: STEMCELL Technologies Inc. - Key offerings
Exhibits124: ZenBio Inc. - Overview
Exhibits125: ZenBio Inc. - Product / Service
Exhibits126: ZenBio Inc. - Key offerings
Exhibits127: Inclusions checklist
Exhibits128: Exclusions checklist
Exhibits129: Currency conversion rates for US$
Exhibits130: Research methodology
Exhibits131: Validation techniques employed for market sizing
Exhibits132: Information sources
Exhibits133: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

TechNavio社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る